UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
10.19
-0.08 (-0.78%)
Jan 21, 2025, 4:00 PM EST - Market closed
UroGen Pharma Market Cap
UroGen Pharma has a market cap or net worth of $430.01 million as of January 21, 2025. Its market cap has decreased by -0.63% in one year.
Market Cap
430.01M
Enterprise Value
298.54M
1-Year Change
-0.63%
Ranking
Category
Stock Price
$10.19
Market Cap Chart
Since May 4, 2017, UroGen Pharma's market cap has increased from $167.38M to $430.01M, an increase of 156.91%. That is a compound annual growth rate of 13.01%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |